91 related articles for article (PubMed ID: 2119218)
1. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia.
Andersson JK; Rybo G
Br J Obstet Gynaecol; 1990 Aug; 97(8):690-4. PubMed ID: 2119218
[TBL] [Abstract][Full Text] [Related]
2. Heavy menstrual bleeding in women with inherited bleeding disorders in use of LNG-IUS: A systematic review and single-arm meta-analysis.
Oliveira JA; Eskandar K; Chagas J; do Nascimento LLO; Ribeiro DD; Rocha ALL; de Oliveira FR
Contraception; 2024 Jul; 135():110450. PubMed ID: 38614274
[TBL] [Abstract][Full Text] [Related]
3. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.
Sayed GH; Zakherah MS; El-Nashar SA; Shaaban MM
Int J Gynaecol Obstet; 2011 Feb; 112(2):126-30. PubMed ID: 21092958
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic amenorrhea in patients at risk for thrombocytopenia.
Martin-Johnston MK; Okoji OY; Armstrong A
Obstet Gynecol Surv; 2008 Jun; 63(6):395-402; quiz 405. PubMed ID: 18492296
[TBL] [Abstract][Full Text] [Related]
5. Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system.
Kailasam C; Cahill D
Patient Prefer Adherence; 2008 Feb; 2():293-302. PubMed ID: 19920976
[TBL] [Abstract][Full Text] [Related]
6. The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.
Kaunitz AM; Inki P
Drugs; 2012 Jan; 72(2):193-215. PubMed ID: 22268392
[TBL] [Abstract][Full Text] [Related]
7. Levonorgestrel intrauterine system versus medical therapy for menorrhagia.
Gupta J; Kai J; Middleton L; Pattison H; Gray R; Daniels J;
N Engl J Med; 2013 Jan; 368(2):128-37. PubMed ID: 23301731
[TBL] [Abstract][Full Text] [Related]
8. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.
Irvine GA; Campbell-Brown MB; Lumsden MA; Heikkilä A; Walker JJ; Cameron IT
Br J Obstet Gynaecol; 1998 Jun; 105(6):592-8. PubMed ID: 9647148
[TBL] [Abstract][Full Text] [Related]
9. Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy.
Xu L; Lee BS; Asif S; Kraemer P; Inki P
Int J Womens Health; 2014; 6():547-54. PubMed ID: 24920936
[TBL] [Abstract][Full Text] [Related]
10. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability.
Tang GW; Lo SS
Contraception; 1995 Apr; 51(4):231-5. PubMed ID: 7796588
[TBL] [Abstract][Full Text] [Related]
11. Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.
Heikinheimo O; Inki P; Schmelter T; Gemzell-Danielsson K
Hum Reprod; 2014 Jun; 29(6):1182-8. PubMed ID: 24682613
[TBL] [Abstract][Full Text] [Related]
12. Menstrual blood loss--a population study. Variation at different ages and attempts to define normality.
Hallberg L; Högdahl AM; Nilsson L; Rybo G
Acta Obstet Gynecol Scand; 1966; 45(3):320-51. PubMed ID: 5922481
[No Abstract] [Full Text] [Related]
13. Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy.
Lähteenmäki P; Haukkamaa M; Puolakka J; Riikonen U; Sainio S; Suvisaari J; Nilsson CG
BMJ; 1998 Apr; 316(7138):1122-6. PubMed ID: 9552948
[TBL] [Abstract][Full Text] [Related]
14. The levonorgestrel intrauterine system in the management of menorrhagia.
Barrington JW; Bowen-Simpkins P
Br J Obstet Gynaecol; 1997 May; 104(5):614-6. PubMed ID: 9166207
[TBL] [Abstract][Full Text] [Related]
15. Medical management of heavy menstrual bleeding: a comprehensive review of the literature.
Bitzer J; Heikinheimo O; Nelson AL; Calaf-Alsina J; Fraser IS
Obstet Gynecol Surv; 2015 Feb; 70(2):115-30. PubMed ID: 25671373
[TBL] [Abstract][Full Text] [Related]
16. A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena.
Gemzell-Danielsson K; Schellschmidt I; Apter D
Fertil Steril; 2012 Mar; 97(3):616-22.e1-3. PubMed ID: 22222193
[TBL] [Abstract][Full Text] [Related]
17. Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland.
Soini T; Hurskainen R; Grénman S; Mäenpää J; Paavonen J; Pukkala E
Obstet Gynecol; 2014 Aug; 124(2 Pt 1):292-299. PubMed ID: 25004338
[TBL] [Abstract][Full Text] [Related]
18. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
Sturridge F; Guillebaud J
Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
[TBL] [Abstract][Full Text] [Related]
19. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Luukkainen T; Toivonen J
Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
[TBL] [Abstract][Full Text] [Related]
20. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial.
Andersson K; Odlind V; Rybo G
Contraception; 1994 Jan; 49(1):56-72. PubMed ID: 8137626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
